Qinheli Biomedical

company

About

Qinheli Biomedical is a tumor micro-environment-responsive drug developer

  • 251 - 500

Details

Last Funding Type
Seed
Last Funding Money Raised
¥60M
Industries
Health Care,Medical
Founded date
Jan 1, 2011
Number Of Employee
251 - 500
Operating Status
Active

Qinheli Biomedical is a tumor micro-environment-responsive drug developer dedicated to the development and production of low-toxic and highly effective patented anti-cancer drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥60M
Qinheli Biomedical has raised a total of ¥60M in funding over 2 rounds. Their latest funding was raised on Apr 1, 2021 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 1, 2021 Private Equity(PE) 1 Detail
Jul 16, 2019 Seed ¥60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Qinheli Biomedical is funded by 2 investors. Yunsheng Touzi and Tengyuan Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Yunsheng Touzi Private Equity(PE)
Tengyuan Fund Seed